These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

668 related items for PubMed ID: 26001140

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
    Lagerwaard FJ, Verstegen NE, Haasbeek CJ, Slotman BJ, Paul MA, Smit EF, Senan S.
    Int J Radiat Oncol Biol Phys; 2012 May 01; 83(1):348-53. PubMed ID: 22104360
    [Abstract] [Full Text] [Related]

  • 3. Stereotactic ablative radiotherapy (SABR) for non-small cell lung cancer.
    Iyengar P, Westover K, Timmerman RD.
    Semin Respir Crit Care Med; 2013 Dec 01; 34(6):845-54. PubMed ID: 24258574
    [Abstract] [Full Text] [Related]

  • 4. Stereotactic ablative body radiation therapy for octogenarians with non-small cell lung cancer.
    Takeda A, Sanuki N, Eriguchi T, Kaneko T, Morita S, Handa H, Aoki Y, Oku Y, Kunieda E.
    Int J Radiat Oncol Biol Phys; 2013 Jun 01; 86(2):257-63. PubMed ID: 23570699
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Stereotactic ablative radiotherapy versus standard radiotherapy in stage 1 non-small-cell lung cancer (TROG 09.02 CHISEL): a phase 3, open-label, randomised controlled trial.
    Ball D, Mai GT, Vinod S, Babington S, Ruben J, Kron T, Chesson B, Herschtal A, Vanevski M, Rezo A, Elder C, Skala M, Wirth A, Wheeler G, Lim A, Shaw M, Schofield P, Irving L, Solomon B, TROG 09.02 CHISEL investigators.
    Lancet Oncol; 2019 Apr 01; 20(4):494-503. PubMed ID: 30770291
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
    Soldà F, Lodge M, Ashley S, Whitington A, Goldstraw P, Brada M.
    Radiother Oncol; 2013 Oct 01; 109(1):1-7. PubMed ID: 24128806
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stereotactic body radiation therapy (stereotactic ablative radiotherapy) for stage I non-small cell lung cancer--updates of radiobiology, techniques, and clinical outcomes.
    Hadziahmetovic M, Loo BW, Timmerman RD, Mayr NA, Wang JZ, Huang Z, Grecula JC, Lo SS.
    Discov Med; 2010 May 01; 9(48):411-7. PubMed ID: 20515609
    [Abstract] [Full Text] [Related]

  • 11. Stereotactic ablative radiotherapy for centrally located early stage non-small-cell lung cancer: what we have learned.
    Chang JY, Bezjak A, Mornex F, IASLC Advanced Radiation Technology Committee.
    J Thorac Oncol; 2015 Apr 01; 10(4):577-85. PubMed ID: 25514807
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Forecasting the impact of stereotactic ablative radiotherapy for early-stage lung cancer on the thoracic surgery workforce.
    Edwards JP, Datta I, Hunt JD, Stefan K, Ball CG, Dixon E, Grondin SC.
    Eur J Cardiothorac Surg; 2016 Jun 01; 49(6):1599-606. PubMed ID: 26796110
    [Abstract] [Full Text] [Related]

  • 14. Predicting Overall Survival After Stereotactic Ablative Radiation Therapy in Early-Stage Lung Cancer: Development and External Validation of the Amsterdam Prognostic Model.
    Louie AV, Haasbeek CJ, Mokhles S, Rodrigues GB, Stephans KL, Lagerwaard FJ, Palma DA, Videtic GM, Warner A, Takkenberg JJ, Reddy CA, Maat AP, Woody NM, Slotman BJ, Senan S.
    Int J Radiat Oncol Biol Phys; 2015 Sep 01; 93(1):82-90. PubMed ID: 26138912
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Lung volume reduction after stereotactic ablative radiation therapy of lung tumors: potential application to emphysema.
    Binkley MS, Shrager JB, Leung AN, Popat R, Trakul N, Atwood TF, Chaudhuri A, Maxim PG, Diehn M, Loo BW.
    Int J Radiat Oncol Biol Phys; 2014 Sep 01; 90(1):216-23. PubMed ID: 25015205
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
    Mahmood S, Bilal H, Faivre-Finn C, Shah R.
    Interact Cardiovasc Thorac Surg; 2013 Nov 01; 17(5):845-53. PubMed ID: 23900381
    [Abstract] [Full Text] [Related]

  • 19. To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer.
    Shultz DB, Diehn M, Loo BW.
    Semin Radiat Oncol; 2015 Apr 01; 25(2):78-86. PubMed ID: 25771411
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.